Neurostar Hospital Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 6.00 Cr
as on 17-11-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.30 Cr
as on 17-11-2024
- Revenue 290.47%
(FY 2023)
- Profit 87.05%
(FY 2023)
- Ebitda 87.07%
(FY 2023)
- Net Worth 0.11%
(FY 2023)
- Total Assets 6.87%
(FY 2023)
About Neurostar Hospital
The Corporate was formerly known as Dr Amit Wagh Neurostar Hospital Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹26.30 Cr.
Pramod Kubade, Amit Wagh, Ajay Ugale, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2019PTC187374
- Company No.
187374
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Neurostar Hospital?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Ugale  | Director | 12-Apr-2021 | Current |
| Pramod Kubade | Director | 12-Apr-2021 | Current |
| Amit Wagh | Director | 19-Oct-2019 | Current |
| Mukund Bilolikar | Director | 12-Apr-2021 | Current |
| Ashish Dhoke | Director | 12-Apr-2021 | Current |
| Rucha Wagh | Director | 19-Oct-2019 | Current |
Financial Performance of Neurostar Hospital.
Neurostar Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 290.47% increase. The company also saw a substantial improvement in profitability, with a 87.05% increase in profit. The company's net worth moved up by a moderate rise of 0.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neurostar Hospital?
In 2023, Neurostar Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 29 Jan 2022 | ₹5.85 Cr | Open |
Bank Of India Creation Date: 08 Sep 2020 | ₹20.45 Cr | Open |
How Many Employees Work at Neurostar Hospital?
Unlock and access historical data on people associated with Neurostar Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neurostar Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neurostar Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
